SAN ANTONIO -- Adding an immune checkpoint inhibitor (ICI) to chemotherapy significantly increased the rate of pathologic complete response (pCR) and reduced residual ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback